HCA Healthcare Dirección

Dirección controles de criterios 2/4

El CEO de HCA Healthcare's es Sam Hazen , nombrado en Jan 2019, tiene una permanencia de 5.25 años. compensación anual total es $21.32M, compuesta por 7.1% salario y 92.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.5% de las acciones de la empresa, por valor de $416.26M. La antigüedad media del equipo directivo y de la junta directiva es de 5.3 años y 8.2 años, respectivamente.

Información clave

Sam Hazen

Chief Executive Officer (CEO)

US$21.3m

Compensación total

Porcentaje del salario del CEO	7.1%
Permanencia del CEO	5.3yrs
Participación del CEO	0.5%
Permanencia media de la dirección	4.5yrs
Promedio de permanencia en la Junta Directiva	8.3yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Sam Hazen en comparación con los beneficios de HCA Healthcare?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	US$5b
Dec 31 2023	US$21m	US$2m	US$5b
Sep 30 2023	n/a	n/a	US$6b
Jun 30 2023	n/a	n/a	US$6b
Mar 31 2023	n/a	n/a	US$6b
Dec 31 2022	US$15m	US$2m	US$6b
Sep 30 2022	n/a	n/a	US$5b
Jun 30 2022	n/a	n/a	US$7b
Mar 31 2022	n/a	n/a	US$7b
Dec 31 2021	US$21m	US$1m	US$7b
Sep 30 2021	n/a	n/a	US$7b
Jun 30 2021	n/a	n/a	US$5b
Mar 31 2021	n/a	n/a	US$5b
Dec 31 2020	US$30m	US$1m	US$4b
Sep 30 2020	n/a	n/a	US$3b
Jun 30 2020	n/a	n/a	US$3b
Mar 31 2020	n/a	n/a	US$3b
Dec 31 2019	US$27m	US$1m	US$4b
Sep 30 2019	n/a	n/a	US$3b
Jun 30 2019	n/a	n/a	US$4b
Mar 31 2019	n/a	n/a	US$4b
Dec 31 2018	US$10m	US$1m	US$4b
Sep 30 2018	n/a	n/a	US$3b
Jun 30 2018	n/a	n/a	US$3b
Mar 31 2018	n/a	n/a	US$3b
Dec 31 2017	US$10m	US$1m	US$2b

Compensación vs. Mercado: La compensación total de Sam($USD21.32M) está por encima de la media de empresas de tamaño similar en el mercado UK ($USD5.62M).

Compensación vs. Ingresos: La compensación de Sam ha aumentado más de un 20%, mientras que los beneficios de la empresa han caído más de un 20% en el último año.

CEO

Sam Hazen (63 yo)

5.3yrs

Permanencia

US$21,315,984

Compensación

Mr. Samuel N. Hazen, also known as Sam, serves as Director at HCA Healthcare, Inc. He serves as Chief Executive Officer of HCA Healthcare Inc. since January 01, 2019 and has been its Director since Septemb...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Samuel Hazen	CEO & Director	5.3yrs	US$21.32m	0.51% $ 416.7m
Jon Foster	Executive VP & COO	1.3yrs	US$8.70m	0.058% $ 47.5m
Erol Akdamar	President of American Group	11.3yrs	US$5.40m	0.046% $ 37.9m
Timothy McManus	President of National Group	7.8yrs	US$5.58m	0.0089% $ 7.4m
Thomas Frist	Founder & Chairman Emeritus	no data	US$362.11k	0.18% $ 150.6m
Michael Marks	CFO & Executive Vice President	no data	sin datos	0.027% $ 21.9m
Chad Wasserman	Senior VP & Chief Information Officer	less than a year	sin datos	0.00060% $ 494.2k
Michael McAlevey	Executive VP and Chief Legal & Administrative Officer	2.3yrs	US$6.47m	0.0015% $ 1.3m
Frank Morgan	Vice President of Investor Relations	2.3yrs	sin datos	sin datos
Kathleen Whalen	Senior VP and Chief Ethics & Compliance Officer	5.3yrs	sin datos	0.0048% $ 4.0m
Deborah Reiner	Senior Vice President of Marketing & Corporate Affairs	6.6yrs	sin datos	0.0026% $ 2.1m
Jennifer Berres	Senior VP & Chief Human Resources Officer	4.5yrs	sin datos	0.0072% $ 5.9m

4.5yrs

Permanencia media

59yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 0J1R se considera experimentado (4.5 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Samuel Hazen	CEO & Director	5.7yrs	US$21.32m	0.51% $ 416.7m
Thomas Frist	Founder & Chairman Emeritus	no data	US$362.11k	0.18% $ 150.6m
Michael Michelson	Independent Director	6.3yrs	US$389.78k	0% $ 0
Robert Dennis	Independent Director	10.3yrs	US$377.95k	0.0016% $ 1.3m
Nancy-Ann DeParle	Independent Director	10.3yrs	US$334.78k	0.0077% $ 6.3m
Thomas Frist	Chairman of the Board	18.3yrs	US$399.61k	0% $ 0
Meg Crofton	Independent Director	5.2yrs	US$319.78k	0.0024% $ 2.0m
Hugh Johnston	Independent Director	2.7yrs	US$339.78k	0.0010% $ 831.8k
Wayne Riley	Independent Director	12.3yrs	US$349.78k	0.0041% $ 3.4m
William Frist	Director	15.3yrs	US$309.70k	0.15% $ 127.6m
Andrea Smith	Independent Director	2.3yrs	US$324.78k	0.0014% $ 1.1m
John McWilliams	Director of HealthONE	no data	sin datos	sin datos

8.3yrs

Permanencia media

64yo

Promedio de edad

Junta con experiencia: La junta directiva de 0J1R se considera experimentada (8.2 años de antigüedad promedio).

HCA Healthcare Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

HCA Healthcare, Inc. Announces Executive Changes

HCA Healthcare, Inc. Announces Management Changes

HCA Healthcare, Inc. Announces Executive Changes

Insider recently sold US$1.2m worth of stock

HCA Healthcare, Inc., Annual General Meeting, Apr 25, 2024

Insider recently sold US$1.4m worth of stock

Recent updates

First quarter dividend of US$0.66 announced

HCA Healthcare, Inc. Declares Quarterly Cash Dividend, Payable on June 28, 2024

First quarter 2024 earnings released: EPS: US$5.94 (vs US$4.92 in 1Q 2023)

Bright Start College Savings Trust Files a Notice of Exempt Solicitation to HCA Healthcare

HCA Healthcare, Inc. Announces Executive Changes

Upcoming dividend of US$0.66 per share

HCA Healthcare’s Sarah Cannon Cancer Institute Implements New Outpatient Model for CAR T-cell Therapy

HCA Healthcare, Inc. Announces Management Changes

HCA Healthcare, Inc. Announces Executive Changes

Insider recently sold US$1.2m worth of stock

Fourth quarter dividend of US$0.66 announced

HCA Healthcare, Inc., Annual General Meeting, Apr 25, 2024

Full year 2023 earnings released: EPS: US$18.96 (vs US$19.44 in FY 2022)

HCA Healthcare, Inc. (NYSE:HCA) announces an Equity Buyback for $6,000 million worth of its shares.

Upcoming dividend of US$0.60 per share at 1.0% yield

HCA Healthcare, Inc. Declares A Quarterly Cash Dividend, Payable on December 28, 2023

Third quarter 2023 earnings released: EPS: US$3.92 (vs US$3.97 in 3Q 2022)

HCA Healthcare Research Institute Announces First U.S. Patients Undergo Innovative Brain Cancer Treatment in New Clinical Trial at HCA Healthcare's Johnston-Willis Hospital

Upcoming dividend of US$0.60 per share at 0.9% yield

Insider recently sold US$1.4m worth of stock

HCA Healthcare, Inc. Declares Quarterly Dividend, Payable on September 29, 2023

Second quarter 2023 earnings released: EPS: US$4.29 (vs US$3.95 in 2Q 2022)

Upcoming dividend of US$0.60 per share at 0.9% yield

HCA Healthcare, Inc. (NYSE:HCA) agreed to acquire 41 urgent care centers in Texas from FastMed Urgent Care, P.C.

Insider recently sold US$1.3m worth of stock

First quarter 2023 earnings released: EPS: US$4.85 (vs US$4.21 in 1Q 2022)

Upcoming dividend of US$0.60 per share at 1.0% yield

Insider recently sold US$457k worth of stock

Insider recently sold US$2.0m worth of stock

HCA Healthcare, Inc. Announces the Appointment of Jon M. Foster as the Executive Vice President and Chief Operating Officer

HCA Healthcare, Inc., Annual General Meeting, Apr 19, 2023

Full year 2022 earnings released: EPS: US$19.15 (vs US$21.52 in FY 2021)

HCA Healthcare, Inc.’s Innovative Approach to Surgical Recovery Promotes Better Outcomes, Decreased Opioid Usage and Faster Recovery Times for Patients

Upcoming dividend of US$0.56 per share

Insider recently sold US$2.2m worth of stock

Insider recently sold US$2.9m worth of stock

Investor sentiment improved over the past week

HCA Healthcare, Inc Announces Executive Changes

HCA Healthcare, Inc. Provides Guidance for the Full Year 2022

HCA Healthcare, Inc. Declares Quarterly Cash Dividend , Payable on December 28, 2022

Third quarter 2022 earnings released: EPS: US$3.91 (vs US$7.13 in 3Q 2021)

Louisiana Childrens Medical Center, Inc. agreed to acquire Tulane Medical Center/Lakeview Regional Medical Center/Tulane Lakeside Hospital from HCA Healthcare, Inc. (NYSE:HCA).

HCA Healthcare, Inc. Announces Retirement of Bruce Moore, President – Service Line and Operations Integration

Upcoming dividend of US$0.56 per share

HCA Healthcare, Inc. Announces Retirement of Longtime Senior Executive Chuck Hall

Insider recently bought US$65k worth of stock

HCA Healthcare, Inc. Declares Quarterly Cash Dividend, Payable on September 30, 2022

First quarter 2022 earnings released: EPS: US$4.21 (vs US$4.21 in 1Q 2021)

Investor sentiment improved over the past week

Upcoming dividend of US$0.56 per share

Insider recently sold US$516k worth of stock

HCA Healthcare, Inc. Appoints Keith Zimmerman as President of the Company’s Kansas City-Based Midamerica Division

Independent Director recently bought US$248k worth of stock

First quarter 2022 earnings released: EPS: US$4.14 (vs US$4.21 in 1Q 2021)

HCA Healthcare Revises Earnings Guidance for the Year 2022

First quarter 2022 earnings released: EPS: US$4.14 (vs US$4.21 in 1Q 2021)

Upcoming dividend of US$0.56 per share

Insider recently sold US$7.4m worth of stock

HCA Healthcare, Inc. Provides Earnings Guidance for the Year 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

HCA Healthcare, Inc., Annual General Meeting, Apr 21, 2022

HCA Healthcare, Inc. (NYSE:HCA) acquired MD Now Medical Centers, Inc. from Brentwood Associates, Inc. and others.

Upcoming dividend of US$0.48 per share

Executive VP & CFO recently sold US$7.5m worth of stock

Third quarter 2021 earnings released: EPS US$7.00 (vs US$1.98 in 3Q 2020)

Senior VP & General Counsel Robert Waterman has left the company

HCA Healthcare, Inc. (NYSE:HCA) agreed to acquire Five Utah Hospitals from Steward Health Care System LLC.

Upcoming dividend of US$0.48 per share

Chief Executive Officer of Park Plaza Hospital Peyton Elliott has left the company